logo
US FDA approves Moderna's next-gen Covid vaccine

US FDA approves Moderna's next-gen Covid vaccine

Moderna's CEO Stephane Bancel said the approval provides a key tool to protect those at high risk of severe Covid-19. (EPA Images pic)
CAMBRIDGE : The US food and drug administration has approved Moderna's next-generation Covid-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the regulator tightened requirements.
The vaccine has also been approved for people aged 12 to 64 with at least one or more underlying risk factors defined by the Centers for Disease Control and Prevention, Moderna said in a statement.
The company said it expects to have the vaccine, called mNEXSPIKE, available for the 2025-2026 respiratory virus season.
'The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from Covid-19,' CEO Stephane Bancel said in the statement.
The department of health and human services, under the leadership of long-time vaccine sceptic Robert F. Kennedy Jr., is tightening regulatory scrutiny on vaccines.
The FDA said on May 20 it planned to require drugmakers to test their Covid booster shots against an inert placebo in healthy adults under 65 for approval, effectively limiting them to older adults and those at risk of developing severe illness.
The Moderna vaccine can be stored in refrigerators rather than freezers, to offer longer shelf life and make distribution easier, especially in developing countries where supply-chain issues could hamper vaccination drives.
The Centers for Disease Control and Prevention, which Kennedy also oversees, said on Thursday that Covid vaccines remain an option for healthy children when parents and doctors agree that it is needed, stopping short of Kennedy's announcement days earlier that the agency would remove the shots from its immunisation schedule.
The CDC announcement eases investor concern to some extent, analysts say, as it keeps the existing framework for older adults and at-risk people who generally seek out the shots.
FDA leaders have said 100 million to 200 million Americans would still be eligible for annual shots.
Moderna is betting on its newer messenger RNA vaccines as it grapples with waning demand for its original Covid vaccine Spikevax and lower-than-expected uptake of its respiratory syncytial virus vaccine.
The approval for mNEXSPIKE was based on late-stage trial data, which showed the shot was not inferior in efficacy compared to Spikevax in individuals aged 12 years and older.
The shot also showed superior efficacy compared to Spikevax in adults 18 years of age and older in the study.
Kennedy has kickstarted a major overhaul of health departments, laying off thousands of employees to align with President Donald Trump's goal of dramatically shrinking the federal government. This has further ignited worries about potential disruptions to the regulatory review of treatments and vaccines.
The CDC's outside panel of vaccine experts in April discussed recommending the booster shots only for populations at risk of severe Covid-19 for the upcoming immunisation campaign.
The FDA approved Novavax's Covid vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.
Conditions that constitute additional risk range from illnesses such as diabetes and heart disease to behaviours like physical inactivity and substance abuse, according to the CDC.
While Moderna's shots, as well as Pfizer-BioNTech's Comirnaty, are mRNA-based, Novavax's vaccine is protein-based and takes longer to manufacture.
Moderna this month withdrew an application seeking approval for its flu-and-Covid combination vaccine candidate to wait for efficacy data from a late-stage trial of its influenza shot.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Asian stocks rally as Trump's ‘Liberation Day' tariffs hit court hurdle
Asian stocks rally as Trump's ‘Liberation Day' tariffs hit court hurdle

Free Malaysia Today

time3 hours ago

  • Free Malaysia Today

Asian stocks rally as Trump's ‘Liberation Day' tariffs hit court hurdle

Investors reacted to the US court blocking tariffs by moving to safe havens, lifting the dollar, S&P 500, and Nasdaq futures. (AP pic) SYDNEY : Asian shares and Wall Street futures climbed in Asia on Thursday after a US federal court blocked President Donald Trump's 'Liberation Day' tariffs from going into effect, sending the dollar up on safe haven currencies. The Manhattan-based Court of International Trade ruled that Trump overstepped his authority by imposing across-the-board duties on imports from nations that sell more to the US than they buy. The White House quickly appealed the decision, and could take it all the way to the Supreme Court if needed, but in the meantime it offered some hope that Trump might back away from the highest tariff levels he had threatened. 'We're just trying to work out what it might mean basically but obviously the market is doing a knee-jerk reaction,' said Ray Attrill, head of FX strategy at NAB. 'So this may be an absolute storm in a teacup or potentially something more significant.' Investors reacted by embracing risk assets and Japan's Nikkei quickly rose 1%, while South Korea's shares added 0.8%. MSCI's broadest index of Asia-Pacific shares outside Japan edged up, awaiting the opening of Chinese markets. S&P 500 futures climbed 1.5%, while Nasdaq futures rose 1.8%. The latter had already been lifted by relief over earnings from Nvidia, which beat sales estimates. The chipmaker and AI darling also projected strong revenues for the current quarter, sending its shares up 4.4% after hours. That news helped offset a Financial Times report that the White House had ordered US firms that offer software used to design semiconductors to stop selling their services to Chinese groups. The New York Times separately reported the US had suspended some sales to China of critical US technologies, including those related to jet engines, semiconductors and certain chemicals. Pushing out rate cuts The news of the court decision hit traditional safe havens, lifting the dollar 0.8% on the Swiss franc to 0.336. It gained 0.6% on the Japanese yen to 145.76 yen, while the euro dipped 0.5% to US$1.1230. Yields on 10-year Treasuries rose 3 basis points to 4.51% and markets further shaved the chance of a Federal Reserve rate cut anytime soon. Minutes of the last Fed meeting showed 'almost all participants commented on the risk that inflation could prove to be more persistent than expected' due to Trump's tariffs. A rate cut in July is now seen as just a 22% chance, while September has come into around 60% having been more than fully priced a month ago. In commodity markets, gold slipped 0.9% to US$3,259 an ounce. Oil prices extended a rally begun on supply concerns as Opec+ agreed to leave their output policy unchanged and as the US barred Chevron from exporting Venezuelan crude.

US dollar declines as traders assess tariff outlook
US dollar declines as traders assess tariff outlook

Free Malaysia Today

time3 hours ago

  • Free Malaysia Today

US dollar declines as traders assess tariff outlook

The dollar fell after Donald Trump said he would double tariffs on imported steel and aluminum to 50% starting June 4. (Reuters pic) TOKYO : The US dollar edged lower on Monday, giving back some of its gains from last week, as markets weighed the outlook for President Donald Trump's tariff policy and its potential to constrict growth and unleash inflation. The greenback starts the week on the back foot after Trump said late on Friday that he plans to double duties on imported steel and aluminum to 50% from Wednesday. The US currency has been whipsawed for weeks by Trump's on-again-off-again trade war, falling when a flare up in tensions stokes worries of a potential US recession. The dollar witnessed weekly tumbles of 3% against major peers in the days after the April 2 'Liberation Day' tariffs and 1.9% two weeks ago, when Trump threatened 50% levies on Europe. Last week, the greenback got a bit of respite, rising 0.3% after talks with the European Union got back on track and a US trade court blocked the bulk of Trump's tariffs on the grounds that he overstepped his authority. Although an appeals court reinstated the duties a day later as it considers the case, and Trump's administration said it had other avenues to implement the levies if it loses in court, many analysts said it shows there are still checks in place on the President's power. The dollar dropped 0.3% to 143.57 yen as of 0023 GMT, giving back some of its more than 1% rally from last week. The euro gained 0.2% to US$1.1372, and sterling advanced 0.3% to US$1.3489. The Australian dollar added 0.3% to US$0.6454. The US dollar index, which measures the currency against six major peers, eased 0.2% to 99.214. The dollar has also been weighed down by fiscal worries in recent weeks, amid a broad 'Sell America' theme that has seen dollar assets from stocks to Treasury bonds dropping. Those concerns come into particular focus this week as the Senate starts considering Trump's sweeping tax cut and spending bill, which will add an estimated US$3.8 trillion to the federal government's US$36.2 trillion in debt over the next decade. Many senators have already said the bill will need major revisions, and Trump said he welcomes changes. The fate of section 899 of the bill could be crucial, according to Barclays analysts. 'S899 would give the US free rein to tax companies and investors from countries deemed to have 'unfair foreign taxes' (and) could be seen as a tax on the US capital account at a time when investor nervousness towards US assets has grown,' they said in a research report. 'Actively reducing foreigners' total return on their US investments would dent inflows and weigh on the dollar, all else equal,' they added. 'While dollar sentiment/positioning remains close to extreme negativity, the path ahead is by no means clear cut.'

Trump offers no rest for lifelong US activist couple
Trump offers no rest for lifelong US activist couple

Free Malaysia Today

time3 hours ago

  • Free Malaysia Today

Trump offers no rest for lifelong US activist couple

Joseph and Joyce Ellwanger insisted they still had a role in protesting Donald Trump's right-wing agenda and expanding presidential power. (AFP pic) MILWAUKEE : They've lost count of how many times they've been arrested, but even with a combined age of 180 years, American couple Joseph and Joyce Ellwanger are far from hanging up their activist boots. The pair, who joined the US civil rights rallies in the 1960s, hope protesting will again pay off against Donald Trump, whose right-wing agenda has pushed the limits of presidential power. 'Inaction and silence do not bring about change,' 92-year-old Joseph, who uses a walker, told AFP at a rally near Milwaukee in late April. He was among a few hundred people protesting the FBI's arrest of Judge Hannah Dugan, who is accused of helping an undocumented man in her court evade migration authorities. By his side – as always – was Joyce, 88, carrying a sign reading 'Hands Off Hannah.' They are certain that protesting does make a difference, despite some Americans feeling despondent about opposing Trump in his second term. 'The struggle for justice has always had so much pushback and difficulty that it almost always appeared as though we'll never win,' Joseph said. 'How did slavery end? How did Jim Crow end? How did women get the right to vote? It was the resilience and determination of people who would not give up,' he added. 'Change does happen.' The couple, who have been married for more than 60 years, can certainly speak from experience when it comes to protesting. Joseph took part in strategy meetings with Martin Luther King Jr – the only white religious leader to do so – after he became pastor of an all-Black church in Alabama at the age of 25. He also joined King in the five-day, 54-mile march from Selma to Montgomery in 1965, which historians consider a pivotal moment in the US civil rights movement. Joyce, meanwhile, was jailed for 50 days after she rallied against the US military training of soldiers from El Salvador in the 1980s. Other causes taken up by the couple included opposing the Iraq war in the early 2000s. 'You do what you have to do. You don't let them stop you just because they put up a blockade. You go around it,' Joyce told AFP. 'We'll do our part' Joseph admitted he would like to slow down, noting the only time he and his wife unplug is on Sunday evening when they do a Zoom call with their three adult children. But Trump has kept them active with his sweeping executive actions – including crackdowns on undocumented migrants and on foreign students protesting at US universities. The threats to younger protesters are particularly concerning for Joyce, who compared those demonstrating today to the students on the streets during the 1960s. 'They've been very non-violent, and to me, that's the most important part,' she said. Joyce also acknowledged the couple likely won't live to see every fight to the end, but insisted they still had a role to play. 'We're standing on the shoulders of people who have built the justice movement and who have brought things forward. So, we'll do our part,' she said. Joyce added that she and Joseph would be protesting again on June 14 as part of the national 'No Kings' rally against Trump. 'More people are taking to the streets, we will also be in the street,' she said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store